Merck KGaA (OTCMKTS:MKKGY – Get Free Report) was the target of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totalling 700 shares, a decrease of 95.3% from the September 30th total of 15,000 shares. Based on an average daily trading volume, of 215,500 shares, the short-interest ratio is currently 0.0 days.
Analysts Set New Price Targets
Separately, The Goldman Sachs Group initiated coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating for the company.
View Our Latest Stock Analysis on Merck KGaA
Merck KGaA Trading Down 0.2 %
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
See Also
- Five stocks we like better than Merck KGaA
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Texas Roadhouse Stock Steering for New Highs This Year
- Compound Interest and Why It Matters When Investing
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.